
    
      This study has double purpose :

        1. To compare the results obtained from the SeptiFast system with the results from
           classical microbiological sampling, in particular hemoculture, for immunosuppressed
           patients presenting sepsis.

        2. To perform a blind assessment of the benefit of septiFast care of these patients.
    
  